Puig Brands SA header image

Puig Brands SA

PUIG

Equity

ISIN ES0105777017 / Valor 134697076

BME Bolsas y Mercados Espanoles - Renta Variable (2025-12-17)
EUR 15.04+0.20%

Puig Brands SA
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Puig Brands SA is a global player in the beauty and fashion industry, known for its innovative approach to creating and marketing a wide range of products. The company operates through a unique model it refers to as "Invisible Beauty," which is executed by 51 makers teams. These teams have been instrumental in generating significant impact, reaching over 10 million direct and indirect beneficiaries across Europe, Latin America, the U.S., Africa, the Middle East, and Asia. This expansive reach is a testament to the company's successful penetration of global markets and its ability to adapt and grow in diverse cultural landscapes. The Makers program, a key initiative by Puig, has been pivotal in evolving the company's projects to not only increase their social impact but also to enhance their financial performance, as evidenced by the growth in turnover. This indicates a strategic blend of creativity, social responsibility, and business acumen in Puig Brands SA's operations, positioning it as a significant entity in the beauty and fashion sectors worldwide.

Summarized from source with an LLMView SourceSector: Finance

Latest Results (27.11.2025):

Puig Brands SA — H1 2025 results (first half of 2025): the company reported strong top‑line and margin progress, with net revenue of €2,299.3m (+7.6% like‑for‑like, +5.9% reported), adjusted EBITDA up 8.6% to €445.4m (19.4% margin), and adjusted net profit of €247.3m. Reported net profit rose to €275.0m, while net debt/adjusted EBITDA stood at 1.4x, and the company reiterated its FY2025 guidance.

Revenue performance

Net revenue €2,299.3m in H1 2025 (+7.6% LFL; +5.9% reported). Fragrance & Fashion: €1,684.7m (+8.6% LFL; 73% of revenue). Makeup: €339.1m (+2.0% LFL; Q2 recovery with +10.5% LFL). Skincare: €275.5m (+8.6% LFL).

Profitability

Adjusted EBITDA €445.4m (+8.6% YoY) with margin up ~50bp to 19.4%. Adjusted net profit €247.3m (10.8% margin). Reported net profit €275.0m (+78.8% YoY), reflecting non‑recurrence of 2024 IPO‑related costs. Adjusted EPS €0.44 for H1 2025.

Margins & costs

Gross margin stable at 75.8%. A&P investment intensity increased by 1.4 percentage points vs H1 2024 to support brand building; this was offset by SG&A and distribution efficiencies and higher D&A from network investments.

Cash flow & balance sheet

Free cash flow from operations improved but remained negative at (€116)m (seasonal working capital build vs (€173)m in H1 2024). Net debt €1,426m and Net Debt / Adjusted EBITDA 1.4x, comfortably below the 2.0x medium‑term threshold.

Regional dynamics

Broad‑based international growth: Americas +10.9% LFL, Asia‑Pacific +16.5% LFL (notably Korea & Japan), EMEA +3.6% LFL.

Operational highlights & brands

Brand momentum: three Puig fragrances (Rabanne, Carolina Herrera, Gaultier) in global top‑10; Charlotte Tilbury #1 prestige makeup UK and #3 in the US. Notable launches/prelaunches include Carolina Herrera’s La Bomba and Charlotte Tilbury product rollouts; Byredo delivered double‑digit niche growth.

Corporate & outlook

Mgmt: Jose Manuel Albesa appointed Deputy CEO (overseeing all divisions) reporting to Marc Puig. Outlook: FY2025 guidance reiterated — LFL revenue growth target 6–8% and continued Adjusted EBITDA margin expansion. Puig remains selective on M&A and maintains financial flexibility.

Summarized from source with an LLMView Source

Key figures

-17.1%1Y
%3Y
%5Y

Performance

30.9%1Y
32.3%3Y
32.3%5Y

Volatility

Market cap

3002 M

Market cap (USD)

Daily traded volume (Shares)

457,870

Daily traded volume (Shares)

1 day high/low

18.035 / 17.615

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Tritax Big Box REIT PLC
Tritax Big Box REIT PLC Tritax Big Box REIT PLC Valor: 22933126
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.37%GBP 1.48
Curaleaf Holdings Inc
Curaleaf Holdings Inc Curaleaf Holdings Inc Valor: 44406864
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.17%CAD 6.49
Viromed Medical AG
Viromed Medical AG Viromed Medical AG Valor: 118813979
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.56%EUR 3.58
First Financial Bankshares Inc
First Financial Bankshares Inc First Financial Bankshares Inc Valor: 139253
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.64%USD 31.29
Attica Bank SA
Attica Bank SA Attica Bank SA Valor: 139193242
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.10%EUR 1.62
Enstar Group Ltd
Enstar Group Ltd Enstar Group Ltd Valor: 2910985
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 337.91
JPMorgan Chase & Co
JPMorgan Chase & Co JPMorgan Chase & Co Valor: 1161460
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.18%USD 314.98
Berkshire Hathaway Inc
Berkshire Hathaway Inc Berkshire Hathaway Inc Valor: 912499
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.93%USD 756,120.01
Arcturus Therapeutics Holdings Inc
Arcturus Therapeutics Holdings Inc Arcturus Therapeutics Holdings Inc Valor: 48461643
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-8.56%USD 6.52
Wells Fargo & Co
Wells Fargo & Co Wells Fargo & Co Valor: 966021
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.43%USD 92.59